Front Matter
Proc. SPIE 6866, Front Matter: Volume 6866, 686601 (13 March 2008); doi: 10.1117/12.792472
Synthesis and Characterization of Nanocrystals for Biomedical Applications
Proc. SPIE 6866, Synthesis and applications of quantum dots and magnetic quantum dots, 686602 (22 February 2008); doi: 10.1117/12.784053
Proc. SPIE 6866, Synthesis and functionalization of non-toxic visible-emitting nanocrystals, 686603 (22 February 2008); doi: 10.1117/12.784058
Proc. SPIE 6866, Synthesis and characterization of scintillating lead-iodide-based nanocrystals, 686604 (13 March 2008); doi: 10.1117/12.784060
Biofunctionalization of Colloidal Nanocrystals
Proc. SPIE 6866, New ligand design to promote water compatibility of luminescent quantum dots and gold nanoparticles, 686606 (22 February 2008); doi: 10.1117/12.764267
Proc. SPIE 6866, Development and characterization of silk fibroin coated quantum dots, 686607 (13 March 2008); doi: 10.1117/12.764061
Resonant-Energy-Transfer-Based Nanosensing
Proc. SPIE 6866, Assembly and intracellular delivery of quantum dot-fluorescent protein bioconjugates, 68660B (13 March 2008); doi: 10.1117/12.763702
Proc. SPIE 6866, Förster resonance energy transfer (FRET) between a fluorescent protein and commercially available quantum dots: a comparison, 68660C (13 March 2008); doi: 10.1117/12.763727
Applications of Colloidal Nanocrystals in Cell Biology I
Proc. SPIE 6866, Quantum dots-based probes conjugated to Annexin V for photostable apoptosis detection and imaging, 68660I (22 February 2008); doi: 10.1117/12.787662
Proc. SPIE 6866, The relationship of QD composition and conjugate to cellular uptake and toxicity, 68660J (22 February 2008); doi: 10.1117/12.762333
Proc. SPIE 6866, Specific cellular delivery and intracellular fate of quantum dot-peptide and quantum dot-polymer nanoassemblies, 68660K (26 February 2008); doi: 10.1117/12.763760
Proc. SPIE 6866, Bioactivation of water-soluble peptidic quantum dot through biotin-streptavidin binding, 68660L (13 March 2008); doi: 10.1117/12.764152
Applications of Colloidal Nanocrystals in Cell Biology II
Proc. SPIE 6866, Dynamics of quantum dots in angiogenic blood vessels: a fluorescence correlation spectroscopy study, 68660P (22 February 2008); doi: 10.1117/12.787650
Applications of Colloidal Quantum Dots in Cancer Diagnostics and Therapy
Proc. SPIE 6866, EGF-conjugated near-infrared quantum dots as nanoprobes for in-vivo imaging of EGFR expression, 68660R (22 February 2008); doi: 10.1117/12.763985
Proc. SPIE 6866, Peptide targeting of quantum dots to human breast cancer cells, 68660S (13 March 2008); doi: 10.1117/12.764107
Proc. SPIE 6866, Use of quantum dot-conjugated antibodies to study intracellular cancer biomarkers in living and fixed cells, 68660T (22 February 2008); doi: 10.1117/12.763359
Applications of Colloidal Quantum Dots in Neuroscience and Radiation Detection
Proc. SPIE 6866, Optimizing protocols for imaging neural cells and tissues using functionalized quantum dots, 68660V (26 February 2008); doi: 10.1117/12.784337
Proc. SPIE 6866, Targeting the human serotonin transporter (hSERT) with quantum dots, 68660X (26 February 2008); doi: 10.1117/12.782801
Poster Session
Proc. SPIE 6866, Two-photon properties of CdSe core ZnS/CdS multishell quantum dots for bioimaging applications, 68660Z (22 February 2008); doi: 10.1117/12.764274
Proc. SPIE 6866, Development of surface-enhanced Raman scattering (SERS) substrates using nanoparticle-based printing inks, 686610 (22 February 2008); doi: 10.1117/12.764577
Proc. SPIE 6866, Evidence-based toxicity of probes, 686613 (22 February 2008); doi: 10.1117/12.765316
Back to Top